[go: up one dir, main page]

WO2000026367A3 - Therapeutics and diagnostics for ocular abnormalities - Google Patents

Therapeutics and diagnostics for ocular abnormalities Download PDF

Info

Publication number
WO2000026367A3
WO2000026367A3 PCT/US1999/025440 US9925440W WO0026367A3 WO 2000026367 A3 WO2000026367 A3 WO 2000026367A3 US 9925440 W US9925440 W US 9925440W WO 0026367 A3 WO0026367 A3 WO 0026367A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutics
diagnostics
ocular abnormalities
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/025440
Other languages
French (fr)
Other versions
WO2000026367A2 (en
Inventor
Gregory S Hageman
Markus H Kuehn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Priority to AU17103/00A priority Critical patent/AU1710300A/en
Publication of WO2000026367A2 publication Critical patent/WO2000026367A2/en
Publication of WO2000026367A3 publication Critical patent/WO2000026367A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Methods and compositions for treating ocular disorders such as retinal detachment and macular degeneration and methods and compositions for prognosing or diagnosing retinal detachment or macular degeneration in a subject are disclosed.
PCT/US1999/025440 1998-10-29 1999-10-29 Therapeutics and diagnostics for ocular abnormalities Ceased WO2000026367A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17103/00A AU1710300A (en) 1998-10-29 1999-10-29 Therapeutics and diagnostics for ocular abnormalities

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18397298A 1998-10-29 1998-10-29
US09/183,972 1998-10-29

Publications (2)

Publication Number Publication Date
WO2000026367A2 WO2000026367A2 (en) 2000-05-11
WO2000026367A3 true WO2000026367A3 (en) 2000-11-09

Family

ID=22675082

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/025440 Ceased WO2000026367A2 (en) 1998-10-29 1999-10-29 Therapeutics and diagnostics for ocular abnormalities

Country Status (2)

Country Link
AU (1) AU1710300A (en)
WO (1) WO2000026367A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9162024B2 (en) 2008-05-08 2015-10-20 Minipumps, Llc Drug-delivery pumps and methods of manufacture
US9180050B2 (en) 2004-08-17 2015-11-10 California Institute Of Technology Implantable intraocular pressure drain
US9199035B2 (en) 2008-05-08 2015-12-01 Minipumps, Llc. Drug-delivery pumps with dynamic, adaptive control
US9308124B2 (en) 2007-12-20 2016-04-12 University Of Southern California Apparatus and methods for delivering therapeutic agents

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7312050B2 (en) * 1998-10-29 2007-12-25 University Of Iowa Research Foundation Nucleic acids encoding interphotoreceptor matrix proteins
CA2833354C (en) 2006-03-14 2015-12-15 University Of Southern California Mems device and method for delivery of therapeutic agents
PL2240220T3 (en) 2008-01-03 2016-09-30 Implantable drug-delivery devices, and apparatus for refilling the devices
US9849238B2 (en) 2008-05-08 2017-12-26 Minipumps, Llc Drug-delivery pump with intelligent control
WO2009137780A2 (en) 2008-05-08 2009-11-12 Replenish Pumps, Llc Implantable pumps and cannulas therefor
WO2009137777A2 (en) 2008-05-08 2009-11-12 Replenish Pumps, Llc Implantable drug-delivery devices, and apparatus and methods for filling the devices
US10286146B2 (en) 2011-03-14 2019-05-14 Minipumps, Llc Implantable drug pumps and refill devices therefor
US9919099B2 (en) 2011-03-14 2018-03-20 Minipumps, Llc Implantable drug pumps and refill devices therefor
US9603997B2 (en) 2011-03-14 2017-03-28 Minipumps, Llc Implantable drug pumps and refill devices therefor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK 24 February 1998 (1998-02-24), KUEHN M.H. & HAGEMAN G.S.: "H. sapiens interphotoreceptor matric porteoglycan 150 (IMPG1)", XP002137252 *
DATABASE GENBANK 24 February 1998 (1998-02-24), KUEHN M.H. ET AL.: "M. fascicularis interphotoreceptor matrix proteoglycan 150", XP002137251 *
GEHRIG A. ET AL.: "Assessment of the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene localised to 6q13-q15 in autosomal dominant Stardgardt-like disease (ADSTGD), progressive bifocal chorioretinal atrophy (PBCRA) and North Carolina macular distrophy (MCDR1).", J. MED. GENETICS, vol. 35, no. 8, August 1998 (1998-08-01), pages 641 - 645, XP000906941 *
KUEHN M.H. & HAGEMAN G.S.: "Characterization of a cDNA encoding IPM150, a novel human interphotoreceptor matrix chondroitin 6-sulfate proteoglycan", INVEST. OPHTHALMOL. & VIS. SCI., vol. 36, no. 4, 15 March 1995 (1995-03-15), pages S510, XP000906940 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180050B2 (en) 2004-08-17 2015-11-10 California Institute Of Technology Implantable intraocular pressure drain
US9308124B2 (en) 2007-12-20 2016-04-12 University Of Southern California Apparatus and methods for delivering therapeutic agents
US9162024B2 (en) 2008-05-08 2015-10-20 Minipumps, Llc Drug-delivery pumps and methods of manufacture
US9199035B2 (en) 2008-05-08 2015-12-01 Minipumps, Llc. Drug-delivery pumps with dynamic, adaptive control

Also Published As

Publication number Publication date
WO2000026367A2 (en) 2000-05-11
AU1710300A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
WO2000026367A3 (en) Therapeutics and diagnostics for ocular abnormalities
CA2248087A1 (en) Improved vision through photodynamic therapy of the eye
AU2002366641A1 (en) Methods for inhibiting ocular processes
CA2407715A1 (en) Diagnostics and therapeutics for macular degeneration-related disorders
WO2003071927A3 (en) Diagnostics and therapeutics for macular degeneration-related disorders
WO2002083175A1 (en) Visual function improving agents
AU4216693A (en) Enzyme product and method for improving bread quality
CA2311356A1 (en) Method for treating alzheimer's disease
CA2359116A1 (en) Substituted porphyrins
IL183284A0 (en) Methods and compositions for treating ocular disorders
WO1999048482A3 (en) Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
WO2003002190A3 (en) Methods for improving damaged retinal cell function
EP1721612A3 (en) Immunemodulating oligosaccharides
WO1997034586A3 (en) Device and method for treating ophthalmic diseases
IL176601A0 (en) Method for diagnosing and improving vision
WO2003039404A3 (en) Methods for treating ocular neovascular diseases
ZA957633B (en) Corneal template and surgical procedure for refractive vision correction.
WO2003039346A3 (en) Diagnostics and therapeutics for ocular abnormalities
WO2003101389A3 (en) Relief of aids symptoms
WO2003073211A3 (en) Methods for continuous performance testing
AU3484895A (en) Eye drops for repairing corneal disturbance
AU2001259775A1 (en) Method for treating retinal degeneration with purinergic receptor agonists
WO2002079456A3 (en) A method for the preparation of immunologically inert amniotic membranes
AU3287400A (en) Cells coexpressing an amyloid precursor protein and an alpha-secretase and theiruses in test methods and diagnostics
WO2003073212A3 (en) Methods for diagnosing akathisia

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 17103

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase